Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI

by Ballantyne, C.M, Bhatt, D.L, Brinton, E.A, Budoff, M.J, Doyle, R.T., Jr, Gibson, C.M, Giugliano, R.P, Granowitz, C., Jacobson, T.A, Jiao, L., Juliano, R.A, Ketchum, S.B, Miller, M., Peterson, B.E, Pinto, D., Steg, P.G, Tardif, J.-C, Verma, S.
Published 2022

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction

by Ballantyne, C.M, Bhatt, D.L, Brinton, E.A, Doyle, R.T., Jr, Gaba, P., Gibson, C.M, Giugliano, R.P, Granowitz, C., Jacobson, T.A, Jiao, L., Juliano, R.A, Ketchum, S.B, Martens, F.M.A.C, Miller, M., Steg, P.G, Tardif, J.-C, the REDUCE-IT Investigators
Published 2022